Amyris is a California-based synthetic biotechnology company that converts plant sugar into hydrogen molecules to produce nutraceutical, beauty and wellness products...
Read moreAmyris is a California-based synthetic biotechnology company that converts plant sugar into hydrogen molecules to produce nutraceutical, beauty and wellness products...
Read more2003
PublicIndependent CompanyNASDAQAMRS
Annual Revenue
$269.8M
Amyris's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 5.9B. Over the last four quarters, Amyris's revenue has grown by 48.6%. Specifically, in Q3 2022's revenue was $71.1M; in Q1 2022, it was $57.7M; in Q4 2021, it was $64.8M; in Q3 2021, Amyris's revenue was $47.9M.